ReviewCurrent atherosclerosis reports2019

PCSK9 Inhibition: New Treatment Options and Perspectives to Lower Atherogenic Lipoprotein Particles and Cardiovascular Risk.

Julia Brandts et al.PubMed ↗Publisher ↗

No numbers read from the abstract.